Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X9DL
|
|||
| Drug Name |
Carboxamide derivative 9
|
|||
| Synonyms |
PMID25399719-Compound-7
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ABBVIE DEUTSCHLAND [DEABBVIE INC [US]
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H26N6O4
|
|||
| Canonical SMILES |
C1COCCN1CC2=NN(C=C2)C3=C(C=CC=N3)C(=O)NC(CC4=CC=CC=C4)C(=O)C(=O)N
|
|||
| InChI |
1S/C24H26N6O4/c25-22(32)21(31)20(15-17-5-2-1-3-6-17)27-24(33)19-7-4-9-26-23(19)30-10-8-18(28-30)16-29-11-13-34-14-12-29/h1-10,20H,11-16H2,(H2,25,32)(H,27,33)
|
|||
| InChIKey |
LNYKWHMNUSKRNS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calpain-2 (CAPN2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Calpain-2 (CAPN2) | Target's Patent Info | [1] | |
| KEGG Pathway | Protein processing in endoplasmic reticulum | |||
| Apoptosis | ||||
| Alzheimer's disease | ||||
| Reactome | Degradation of the extracellular matrix | |||
| WikiPathways | Focal Adhesion | |||
| Integrated Pancreatic Cancer Pathway | ||||
| Alzheimers Disease | ||||
| Integrin-mediated Cell Adhesion | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.